Current Report Filing (8-k)
November 04 2020 - 4:35PM
Edgar (US Regulatory)
United States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
October 30, 2020
Date of Report (Date of earliest event reported)
Orisun Acquisition Corp.
(Exact Name of Registrant as Specified in its
Charter)
Delaware
|
|
001-39014
|
|
83-2479505
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
555 Madison Avenue, Room 543
New York, NY
|
|
10022
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including
area code: (631) 482-6032
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☒
|
Written communications pursuant to Rule 425 under the Securities Act
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
|
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on
which registered
|
Units, each consisting of one share of Common Stock, $0.00001 par value, one Redeemable Warrant to acquire one-half of one share of Common Stock, and one Right to acquire one-tenth (1/10) of a share of Common Stock
|
|
ORSNU
|
|
NASDAQ Capital Market
|
Common Stock
|
|
ORSN
|
|
NASDAQ Capital Market
|
Warrants
|
|
ORSNW
|
|
NASDAQ Capital Market
|
Rights
|
|
ORSNR
|
|
NASDAQ Capital Market
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the
Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☒
If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
IMPORTANT NOTICES
Important Notice Regarding Forward-Looking
Statements
This Current Report on Form 8-K contains
certain “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act
of 1934, both as amended. Statements that are not historical facts, including statements about the pending transactions among Orisun
Acquisition Corp. (“Orisun”), Ucommune International Ltd (“Purchaser”), Everstone International Ltd (“Merger
Sub”), and Ucommune Group Holdings Limited (“Ucommune”) and the transactions contemplated thereby, and the parties’
perspectives and expectations, are forward-looking statements. Such statements include, but are not limited to, statements regarding
the proposed transaction, including the anticipated initial enterprise value and post-closing equity value, the benefits of the
proposed transaction, integration plans, expected synergies and revenue opportunities, anticipated future financial and operating
performance and results, including estimates for growth, the expected management and governance of the combined company, and the
expected timing of the transactions. The words “expect,” “believe,” “estimate,” “intend,”
“plan” and similar expressions indicate forward-looking statements. These forward-looking statements are not guarantees
of future performance and are subject to various risks and uncertainties, assumptions (including assumptions about general economic,
market, industry and operational factors), known or unknown, which could cause the actual results to vary materially from those
indicated or anticipated.
Such risks and uncertainties include, but
are not limited to: (i) risks related to the expected timing and likelihood of completion of the pending transaction, including
the risk that the transaction may not close due to one or more closing conditions to the transaction not being satisfied or waived,
such as regulatory approvals not being obtained, on a timely basis or otherwise, or that a governmental entity prohibited, delayed
or refused to grant approval for the consummation of the transaction or required certain conditions, limitations or restrictions
in connection with such approvals; (ii) risks related to the ability of Orisun and Ucommune to successfully integrate the businesses;
(iii) the occurrence of any event, change or other circumstances that could give rise to the termination of the applicable transaction
agreements; (iv) the risk that there may be a material adverse change with respect to the financial position, performance, operations
or prospects of Ucommune or Orisun; (v) risks related to disruption of management time from ongoing business operations due to
the proposed transaction; (vi) the risk that any announcements relating to the proposed transaction could have adverse effects
on the market price of Orisun’s securities; (vii) the risk that the proposed transaction and its announcement could have
an adverse effect on the ability of Ucommune and Orisun to retain customers and retain and hire key personnel and maintain relationships
with their suppliers and customers and on their operating results and businesses generally; (viii) the risk that the combined company
may be unable to achieve cost-cutting synergies or it may take longer than expected to achieve those synergies; and (ix) risks
associated with the financing of the proposed transaction. A further list and description of risks and uncertainties can be found
in Orisun’s Annual Report on Form 10-K for the fiscal year ending December 31, 2019 filed with the SEC, in Orisun’s
quarterly reports on Form 10-Q filed with the SEC subsequent thereto and in the Registration Statement on Form F-4 and proxy statement
that will be filed with the SEC by the Purchaser in connection with the proposed transactions, and other documents that the parties
may file or furnish with the SEC, which you are encouraged to read. Should one or more of these risks or uncertainties materialize,
or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such
forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements. Forward-looking
statements relate only to the date they were made, and Orisun, Purchaser, Merger Sub, Ucommune, and their subsidiaries undertake
no obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required
by law or applicable regulation.
Additional Information and Where to Find
It
In connection with the transaction described
herein, Purchaser has filed a registration statement on Form F-4, which includes a preliminary proxy statement, with the Securities
and Exchange Commission (the “SEC”) and Orisun and Purchaser will file additional relevant materials with SEC. A proxy
statement and a proxy card will be mailed to Orisun’s stockholders as of a record date to be established for voting at the
stockholders’ meeting relating to the proposed transactions. Stockholders will also be able to obtain a copy of the Registration
Statement on Form F-4 and proxy statement without charge from the Company. The Registration Statement on Form F-4 and proxy statement,
once available, may also be obtained without charge at the SEC’s website at www.sec.gov or by writing to Orisun at 555 Madison
Avenue, Room 543 New York, NY. INVESTORS AND SECURITY HOLDERS OF ORISUN ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS
OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS IN CONNECTION WITH THE TRANSACTIONS THAT ORISUN WILL FILE WITH THE SEC
WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT ORISUN, UCOMMUNE AND THE TRANSACTIONS.
Participants in Solicitation
Orisun, Purchaser, Merger Sub, Ucommune,
certain shareholders of the Company, and their respective directors, executive officers and employees and other persons may be
deemed to be participants in the solicitation of proxies from the holders of Orisun common stock in respect of the proposed transaction.
Information about Orisun’s directors and executive officers and their ownership of Orisun’s common stock is set forth
in Orisun’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC. Other information regarding
the interests of the participants in the proxy solicitation will be included in the proxy statement pertaining to the proposed
transaction when it becomes available. These documents can be obtained free of charge from the sources indicated above.
Item 1.01 Entry into a Material definitive
Agreement.
As previously announced, on August 18, 2020,
Orisun Acquisition Corp. (“Orisun” or the “Company”), Ucommune International Ltd (“PubCo”)
and Ucommune Group Holding Limited (“Ucommune”) entered into backstop agreements (each, a “Backstop
Agreement”) with 14 investors, pursuant to which the investors agreed to invest no less than $53 million by (i) acquiring
Orisun’s common stock in the open market or in private transactions prior to the closing of the Business Combination at the
then prevailing market price of the shares, or (ii) acquiring newly issued PubCo class A ordinary shares concurrently
with the closing of the business combination at a price of $10.10 per share (the “PIPE Shares”).
On October 30, Orisun, PubCo and Ucommune entered
into additional Backstop Agreements with four additional investors, and terminated one Backstop Agreement in an amount of $100,000
with one of the initial 14 investors. As of November 4, 2020, 17 investors had entered into Backstop Agreements and agreed to invest
an aggregate of $66 million by either acquiring PIPE Shares or Orisun’s common stock in the open market.
Pursuant to the Backstop Agreements, PubCo
agreed that, after the closing of the business combination and subject to certain conditions set forth in the Backstop Agreements,
PubCo will file with the SEC a registration statement registering the resale of the PIPE Shares (the “Resale Registration
Statement”), and PubCo will use its commercially reasonable efforts to have the Resale Registration Statement declared
effective as soon as practicable after the filing thereof. In addition, subject to certain exceptions, if any time after the closing
of the business combination, PubCo proposes to file a registration statement under the Securities Act with respect to its securities,
under the Backstop Agreement, PubCo will give notice to holders of PIPE Shares as to the proposed filing and offer such stockholders
an opportunity to register the sale of such number of their registrable securities as they request in writing.
In addition, on November 2, 2020, Orisun issued
an unsecured promissory note in an amount of $444,002 to Ucommune (“Note”), in exchange for Ucommune depositing
such amount into the Orisun’s trust account in order to extend the amount of time it has available to complete a business
combination.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation
under an Off-Balance Sheet Arrangement of a Registrant.
The disclosure of Orisun’s issuing Note
to Ucommune set forth under Item 1.01 of this Current Report on Form 8-K is incorporated by reference herein. The Note does not
bear interest and matures upon closing of a business combination by the Company. In addition, the Note may be converted by the
holder into units of the Company identical to the units issued in the Company’s initial public offering at a price of $10.00
per unit.
Item 3.02 Unregistered Sales of Equity Securities
The Backstop Agreement disclosure set forth
under Item 1.01 of this Current Report on Form 8-K is incorporated by reference herein. The PIPE Shares potentially issuable pursuant
to the Backstop Agreement will, if issued, be issued in reliance on the exemption from registration set forth in Section 4(a)(2)
of the Securities Act of 1933, as amended, and/or Regulation D and Regulation S thereunder.
Item 8.01 Other Events.
On November 4, 2020, the Company issued a press
release announcing issuing the Note. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K
and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
*
|
Furnished but not filed.
|
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: November 4, 2020
ORISUN ACQUISITION CORP.
By:
|
/s/ Wei Chen
|
|
Name:
|
Wei Chen
|
|
Title:
|
Chief Executive Officer
|
|
Orisun Acqusition (NASDAQ:ORSNU)
Historical Stock Chart
From May 2024 to Jun 2024
Orisun Acqusition (NASDAQ:ORSNU)
Historical Stock Chart
From Jun 2023 to Jun 2024